On June 2nd, 2016, Summit Forum for Neural Restoration and Functional Reconstruction held by Yinfeng Biological Engineering Group Co., Ltd. and co-organized by the editorial department of Tsinghua University’s Translational Neuroscience and Clinics is closed successfully in Fengda International Hotel Beijing.

    2016 Summit Forum for Neural Restoration and Functional Reconstruction aims at research and transfer in technology products about neural restoration and functional reconstruction, the latest news and development tendency about bio-medical technology of neural restoration and functional reconstruction. According to the researchers, at present, cell treatment is the most promising treatment technology to prevent and cure nerve injuries and neurodegenerative disease, which is also the most complicated bio-technology and issue attracted attention and discussion.

    The forum is held by four famous neurologists from Beijing Tiantan Hospital of Capital Medical University, Xuanwu Hospital of Capital Medical University, Qilu Hospital of Shandong University, the 302 Hospital of Chinese PLA.

    QuTingyu, the director of Stem cell laboratory in University of illionois published theme report around neural stem cells’ mechanism and application and translational medicine, which referred to construction and application of fetal origins neural stem cell and broad prospects of clinical application that people’s neural stem cell induce dopaminergic neurons precursor cells. Then, professor Luan zuo from Navy General hospital introduced effect and application on stem cell’s paracrine factor. And Professor Chen lin from Second Hospital of Tsinghua University introduce normalized clinical translation of neural prosthetics and cell transplantation. Besides, professor Han Hongyan from Aviation General Hospital of China Medical University made a speech about new treatment with vascular bypass curing Moyamoya disease and neural function restoration.

    During experts visit Yinfeng Biological Engineering Co., Ltd which is Yinfeng Biological Group’s new biotechnology products research base in Beijing, Sheng Dewei, the president of Yinfeng Biological Group and DongBai xiang, general manager of Beijnig yinfeng company detailedly introduced technical progress on human neural stem cells, human oligodendrocyte precursor cells, human fetal dopamine neurons, stem cell’s paracrine factors and human mesenchymal stem cells’ serum-free medium.

    With this, 2016 summit forum for neural restoration and functional reconstruction is closed successfully.